A clinical trial of ATTATHI CHOORANAM in the management of RAKTHA SOORAI VAAYU (POLY CYSTIC OVARIAN SYNDROME)

A PROSPECTIVE OPEN LABELLED, NON-RANDOMIZED, PHASE II CLINICAL TRIAL OF â??ATTATHI CHOORANAMâ?? IN THE MANAGEMENT OF â??RAKTHA SOORAI VAAYUâ?? (POLY CYSTIC OVARIAN SYNDROME)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019119

Enrollment

Registered

2019-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: ATTATHI CHOORANAM: 40mg/kg for three times/day A/F orally 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: I. Marital Status : Married / Unmarried II. Symptoms -Irregular menstruation, oligomenorrhoea (or) amenorrhoea (or) dysmenorrhoea (or) dysfunctional uterine bleeding -Hirsuitism and obesity III. Patient willing to take USG pelvis IV. Patient willing to undergo routine blood investigation V. USG pelvis showing polycystic ovaries VI. Patient willing to participate in trial and signing in consent form

Exclusion criteria

Exclusion criteria: I. History of recent hormone therapy (within one year) II. Pregnancy. III. Lactating mother. IV. History of renal disease V. History of Liver diseas VI. Uterine anomalies

Design outcomes

Primary

Measure	Time frame
Diagnosis of RAKTHA SOORAI VAAYU and evaluation of the therapeutic efficacy of Attathi chooranam. It is assessed by the improvement in the score of irregular menstruation (Intermenstrual period & duration of bleeding) before and after treatment.Timepoint: 48 days	—

Secondary

Measure	Time frame
Changes in the polycystic swellings of the ovaries in USG pelvis and reduction of other symptoms.Timepoint: 48 days	—

Countries

India

Contacts

Public ContactDr A Manoharan MD PhD

Government Siddha Medical College and Hospital Palayamkottai

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026